MMP9 and meningioma: The assessment of intra-tumoral MMP-9 levels revealed significantly higher concentrations in glioblastoma (8 ng/ml) and brain metastases (4 ng/ml) compared to meningioma (1 ng/ml; p<0.001; Figures 2A–C).